Overview

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary to pathologic myopia (PM-CNV).
Phase:
Phase 4
Details
Lead Sponsor:
Instituto de Olhos de Goiania
Treatments:
Bevacizumab